This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Paxillin
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
== Disease == | == Disease == | ||
PXN has enhanced expression in several types of cancer PXN mutations are associated with lung cancer tumor growth<ref>PMID:18172305</ref>. | PXN has enhanced expression in several types of cancer PXN mutations are associated with lung cancer tumor growth<ref>PMID:18172305</ref>. | ||
| - | |||
| - | == Relevance == | ||
== Structural highlights == | == Structural highlights == | ||
Revision as of 09:34, 15 June 2016
| |||||||||||
3D structures of paxillin
Updated on 15-June-2016
References
- ↑ Tumbarello DA, Brown MC, Turner CE. The paxillin LD motifs. FEBS Lett. 2002 Feb 20;513(1):114-8. PMID:11911889
- ↑ Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, Schwartz S, Faoro L, Wang YC, Girard L, Tretiakova MS, Ahmed S, Zumba O, Soulii L, Bindokas VP, Szeto LL, Gordon GJ, Bueno R, Sugarbaker D, Lingen MW, Sattler M, Krausz T, Vigneswaran W, Natarajan V, Minna J, Vokes EE, Ferguson MK, Husain AN, Salgia R. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res. 2008 Jan 1;68(1):132-42. doi: 10.1158/0008-5472.CAN-07-1998. PMID:18172305 doi:http://dx.doi.org/10.1158/0008-5472.CAN-07-1998
